Veracyte Ownership | Who Owns Veracyte?

Overview Forecast RevenueFinancials Chart Transcripts

Veracyte Ownership Summary

Veracyte is owned by 113.27% institutional investors, 0.45% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.69% of VCYT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.92% of its assets in Veracyte shares.

VCYT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Veracyte	113.27%	0.45%	-13.72%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	13.05M	16.69%	$448.08M
Vanguard group	8.50M	10.87%	$291.95M
Blackrock	7.79M	10.42%	$168.88M
Artisan partners limited partnership	7.37M	9.42%	$253.03M
Fmr	6.80M	8.69%	$233.30M
Ark investment management	4.47M	5.71%	$153.31B
State street	4.20M	5.37%	$144.17M
Wellington management group llp	3.37M	4.31%	$115.80M
Dimensional fund advisors lp	3.12M	3.99%	$107.04M
Arrowmark colorado	2.55M	3.25%	$87.40M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Perkins capital management	79.68K	2.41%	$2.74M
Iron triangle partners lp	485.00K	2.37%	$16.65M
Palisades investment partners	158.14K	2.13%	$5.43M
Arrowmark colorado	2.55M	1.62%	$87.40M
Summit creek advisors	248.13K	1.24%	$8.52M
Silverarc capital management	235.79K	1.09%	$8.09M
Efg asset management (north america)	219.98K	0.98%	$7.56M
Oberweis asset management inc/	721.69K	0.95%	$24.78M
Granite investment partners	476.98K	0.93%	$16.37B
Ark investment management	4.47M	0.91%	$153.31B

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	13.05M	0.01%	5.32M
Champlain investment partners	1.17M	0.30%	1.17M
Artisan partners limited partnership	7.37M	0.36%	1.05M
State street	4.20M	0.01%	1.03M
Fred alger management	767.48K	0.10%	767.48K

Top Sellers

Holder	Shares	% Assets	Change
Driehaus capital management	-	-	-1.35M
Fmr	6.80M	0.01%	-1.31M
Qube research	12.71K	0.00%	-971.07K
Assenagon asset management	27.04K	0.00%	-803.06K
Squarepoint ops	166.86K	0.01%	-730.52K

New Positions

Holder	Shares	% Assets	Change	Value
Champlain investment partners	1.17M	0.30%	1.17M	$40.06M
Fred alger management	767.48K	0.10%	767.48K	$26.35M
William blair investment management	677.91K	0.06%	677.91K	$23.27M
Iron triangle partners lp	485.00K	2.37%	485.00K	$16.65M
Jupiter asset management	394.96K	0.12%	394.96K	$13.56M

Sold Out

Holder	Change
Newedge advisors	-2.00
Global financial private client	-5.00
True wealth design	-6.00
Kohmann bosshard financial services	-6.00
Opal wealth advisors	-13.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	283	5.99%	88,589,496	7.86%	113	1.03%	161	21.97%	83	-15.31%
Jun 30, 2025	273	-5.21%	85,426,396	1.00%	109	0.93%	138	1.47%	98	-8.41%
Mar 31, 2025	9	-97.20%	3,530,599	-95.70%	4	0.04%	5	-96.84%	3	-97.41%
Dec 31, 2024	301	2.73%	77,106,580	-5.52%	100	0.89%	145	-9.94%	109	22.47%
Sep 30, 2024	292	22.18%	81,612,672	-0.60%	105	0.88%	162	38.46%	88	7.32%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	4.66M	5.92%	-
ARK Innovation ETF	2.96M	3.77%	-45.42K
Vanguard US Total Market Shares ETF	2.46M	3.16%	2.69K
Vanguard Total Stock Mkt Idx Inv	2.44M	3.11%	-51.87K
ARK Disruptive Innovation Full Composite	2.36M	3.00%	-119.19K
Vanguard Explorer Inv	2.28M	2.91%	-385.96K
Fidelity Select Medical Tech and Devcs	2.00M	2.54%	-230.00K
Vanguard Small Cap Index	1.90M	2.42%	-13.32K
iShares Russell 2000 ETF	1.89M	2.41%	-
Fidelity Select Health Care	1.40M	1.78%	-120.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 04, 2025	McGuire Annie	SVP, General Counsel	Sell	$33.91K
Dec 04, 2025	McGuire Annie	SVP, General Counsel	Sell	$33.35K
Dec 04, 2025	Chambers Rebecca	Chief Financial Officer	Sell	$397.95K
Dec 04, 2025	Chambers Rebecca	Chief Financial Officer	Sell	$224.01K
Dec 04, 2025	Stapley Marc	Chief Executive Officer	Sell	$208.61K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	27
2025 Q3	-	2
2025 Q2	-	3
2025 Q1	-	12
2024 Q4	-	13

VCYT Ownership FAQ

Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 113.27%, followed by 0.45% insiders and -13.72% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 45.24%, which Veracyte exceeds.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Blackrock funding, inc. /de (13.05M shares, 16.69%), Vanguard group (8.5M shares, 10.87%), and Blackrock (7.79M shares, 10.42%). Together, they hold 37.99% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Perkins capital management is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.41% of its assets in 79.68K Veracyte shares, valued at 2.74M$.

Who is the top mutual fund holder of Veracyte shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Veracyte shares, with 5.92% of its total shares outstanding invested in 4.66M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools